PharmVar GeneFocus: CYP2D6
Copyright policy )PharmVar GeneFocus: CYP2D6
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism of numerous drugs and, thus, can impact drug efficacy and safety. This GeneFocus provides a comprehensive overview and summary of CYP2D6 genetic variation and describes how the information provided by PharmVar is utilized by the Pharmacogenomics Knowledgebase (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
- Mayo Clinic United States
- Stanford University United States
- University of Otago New Zealand
- University of Missouri United States
- Hartford Hospital United States
Polymorphism, Genetic, Cytochrome P-450 CYP2D6, Pharmaceutical Preparations, Pharmacogenetics, Knowledge Bases, Databases, Genetic, Genetic Variation, Humans
Polymorphism, Genetic, Cytochrome P-450 CYP2D6, Pharmaceutical Preparations, Pharmacogenetics, Knowledge Bases, Databases, Genetic, Genetic Variation, Humans
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).204 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1%
Citations provided by BIP!Popularity provided by BIP!